Concepedia

Billy Lin

BL

Statistics

Publications

5

Citations

258

H-Index

5

Active since

2015

Affiliations

National Institutes of Health(Current)

National Institute of Diabetes and Digestive and Kidney Diseases

National Center for Advancing Translational Sciences

University of Kansas

Billy Lin is an author at National Institutes of Health specializing in pharmacology, viral hepatitis treatment, and antiviral pharmacology.

Publications per year

2015–2017

5

Publications

5

Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection

Shanshan He, Billy Lin, Virginia Chu et al. · Science Translational Medicine · 2015 · 153 citations

, , +17

Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection

Shanshan He, Jingbo Xiao, Andrés E. Dulcey et al. · Journal of Medicinal Chemistry · 2015 · 35 citations · Full text

, , +17

High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors

Shanshan He, Prashi Jain, Billy Lin et al. · ACS Combinatorial Science · 2015 · 30 citations · Full text

, , +17

Evaluation of Antiviral Drug Synergy in an Infectious HCV System

Billy Lin, Shanshan He, Hyung Joon Yim et al. · Antiviral Therapy · 2015 · 26 citations · Full text

, , +17

Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle

Shanshan He, Kelin Li, Billy Lin et al. · Journal of Medicinal Chemistry · 2017 · 14 citations · Full text

, , +17

1–5 of 5